VST therapy harnesses Virus-Specific T Cells to selectively target virus-infected cells or virus-related tumors. By expanding these immune cells in the lab, clinicians can provide patients with a highly personalized therapy that enhances immune defense, prevents viral relapse, and complements conventional treatments. Organizations like Xellera Therapeutics leverage VST technology to e... https://viewpen.online/the-role-of-virus-specific-t-cells-in-modern-immunotherapy/